ArticleBMC public health2025
Trends in kidney and renal pelvis cancer mortality and associated risk factors in the United States.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundKidney and renal pelvis cancer (KRPC) is a leading cause of cancer death in the United States, yet the mortality trends by sociodemographic characteristics are not well understood.
methodsThis serial cross-sectional analysis used National Centre for Health Statistics data (1999–2020) to examine kidney and renal pelvis cancer mortality trends among individuals aged ≥ 20, stratified by sex, age, race/ethnicity, and county-level socioeconomic status (SES) (Yost index) and rurality. County-level SES was categorized into distribution-based quintiles, where higher quintiles represented greater SES. Age-standardized mortality trends and average annual percent change were calculated, and age-adjusted multivariate quasi-Poisson regression assessed mortality relative to county-level factors.
resultsFrom 1999 to 2020, overall KRPC mortality declined (average annual percent change [AAPC]: -0.9%, 95% CI [-1.0%, -0.8%]), with decreases observed among men (-1.0%) and women (-1.2%). Black individuals had the most substantial decline (AAPC: -1.3%, 95% CI [-1.8%, -0.7%]) compared with all other racial groups. American Indian and Alaska Native individuals showed no significant changes over the study period. KRPC mortality was approximately 1.2 times higher in counties in the lowest SES quintile compared with the highest quintile. Counties with the highest degree of rurality tended to have the greatest risk of KRPC (Complete rural, < 2500 vs. Metropolitan, > 1 million, 1.0 vs. 0.6).
conclusionsThe mortality trends varied by demographics. The close association of mortality with rurality highlights the necessity for focused public health interventions to address specific demographic needs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.